Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus

查看全文 作　　者：Naru [1]Zhang;Rudragouda [2]Channappanavar;Cuiqing [1]Ma;Lili [1]Wang;Jian [1,3,6]Tang;Tania [4]Garron;Xinrong [4]Tao;Sumaiya [1]Tasneem;Lu [5]Lu;Chien-Te K [4]Tseng;Yusen [3,6]Zhou;Stanley [2]Perlman;Shibo [1,5]Jiang;Lanying [1]Du

机构地区：[1]Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA;[2]Department of Microbiology, University of Iowa, Iowa City, IA, USA;[3]State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China;[4]Department of Microbiology and Immunology and Center for Biodefense and Emerging Disease, University of Texas Medical Branch, Galveston, TX, USA;[5]Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai, Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, China;[6]Xiang-Ya Medical College, Central South University, Changsha. China

出　　处：《Cellular & Molecular Immunology》索引2016年第13卷第2期,共11页

关键词：亚单位疫苗冠状病毒受体结合呼吸综合征中东结构域弗氏佐剂中和抗体

相关文献

参考文献（72）
引证文献（15）
耦合文献（40）

参考文献(72)

引证文献(15)

耦合文献(40)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus

参考文献(72)

引证文献(15)

耦合文献(40)

用户提示